FDG-PET/CT in der onkologie

Translated title of the contribution: FDG-PET/CT in oncology

B. J. Krause, T. Beyer, A. Bockisch, D. Delbeke, J. Kotzerke, V. Minkov, M. Reiser, N. Willich, P. Bartenstein, R. P. Baum, W. Burchert, U. Haberkorn, R. Kluge, W. H. Knapp, T. Kuwert, E. Nitzsche, S. N. Reske, P. Reuland, H. Schicha, O. SchoberM. Schwaiger, U. Stabell, J. Van Den Hoff

Research output: Contribution to journalReview articlepeer-review

59 Scopus citations

Abstract

FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

Translated title of the contributionFDG-PET/CT in oncology
Original languageGerman
Pages (from-to)291-301
Number of pages11
JournalNuklearMedizin
Volume46
Issue number6
DOIs
StatePublished - 2007

Fingerprint

Dive into the research topics of 'FDG-PET/CT in oncology'. Together they form a unique fingerprint.

Cite this